Assignee
ATHERSYS INC
US·25 granted patents·6 pending applications·300 citations·filing 1999–2018
Top patents by PatentIndex Score
31 records- 0197US6361972B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted Mar 26, 2002·72 cites·58 claims
- 0296US6410266B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted Jun 25, 2002·50 cites·49 claims
- 0393US6623958B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted Sep 23, 2003·27 cites·29 claims
- 0493US6524818B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted Feb 25, 2003·23 cites·4 claims
- 0592US6670185B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted Dec 30, 2003·16 cites·47 claims
- 0692US6541221B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted Apr 1, 2003·17 cites·6 claims
- 0789US11000546B2Immunomodulatory properties of MAPCs and uses thereofATHERSYS INC·Filed 2018·Granted May 11, 2021·4 cites·24 claims
- 0889US6524824B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted Feb 25, 2003·10 cites·3 claims
- 0988US6740503B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted May 25, 2004·19 cites·19 claims
- 1086US7033782B2Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2001·Granted Apr 25, 2006·6 cites·12 claims
- 1186US6602686B1Compositions and method for non-targeted activation of endogenous genesATHERSYS INC·Filed 1999·Granted Aug 5, 2003·28 cites·47 claims
- 1283US7981896B2Pyrazoles for the treatment of obesity and other CNS disordersATHERSYS INC·Filed 2011·Granted Jul 19, 2011·10 cites·4 claims
- 1382US7935830B2Tricyclic indeno-pyrrole derivatives as serotonin receptor modulatorsATHERSYS INC·Filed 2009·Granted May 3, 2011·3 cites·3 claims
- 1478US11351202B2MAPC treatment of brain injuries and diseasesATHERSYS INC·Filed 2017·Granted Jun 7, 2022·1 cites·24 claims
- 1576US7423056B2Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulatorsATHERSYS INC·Filed 2005·Granted Sep 9, 2008·2 cites·4 claims
- 1673US7316923B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2000·Granted Jan 8, 2008·2 cites·50 claims
- 1768US6897066B1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 1999·Granted May 24, 2005·10 cites·7 claims
- 1864US2007122391A1Compositions and methods for non-targeted activation of endogenous genesATHERSYS INC·Filed 2005·Application pending·0 cites
- 1959US7981919B2Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulatorsATHERSYS INC·Filed 2008·Granted Jul 19, 2011·0 cites·1 claims
- 2059US7855224B2Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disordersATHERSYS INC·Filed 2008·Granted Dec 21, 2010·0 cites·1 claims
- 2158US2006025601A1Tricyclic indeno-pyrrole derivatives as serotonin receptor modulatorsATHERSYS INC·Filed 2005·Application pending·0 cites
- 2258US2004018624A1Compositions and methods for making mutations in cell lines and animalsATHERSYS INC·Filed 2002·Application pending·0 cites
- 2356US7893051B2Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereofATHERSYS INC·Filed 2007·Granted Feb 22, 2011·0 cites·15 claims
- 2456US7528262B2Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disordersATHERSYS INC·Filed 2006·Granted May 5, 2009·0 cites·4 claims
- 2551US7718647B2Substituted azepine derivatives as serotonin receptor modulatorsATHERSYS INC·Filed 2005·Granted May 18, 2010·0 cites·5 claims
- 2649US7897634B2Pyrazoles for the treatment of obesity and other CNS disordersATHERSYS INC·Filed 2007·Granted Mar 1, 2011·0 cites·8 claims
- 2746US7947691B2Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereofATHERSYS INC·Filed 2005·Granted May 24, 2011·0 cites·10 claims
- 2843US7319103B2Non-imidazole tertiary amines as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disordersATHERSYS INC·Filed 2005·Granted Jan 15, 2008·0 cites·5 claims
- 2942US2004081970A1Calcium-sensing receptor 2 (CaR2) and methods for usingATHERSYS INC·Filed 2002·Application pending·0 cites
- 3036US2004082018A1Methods for using osteocalcinATHERSYS INC·Filed 2002·Application pending·0 cites
- 3134US2004224378A1Methods for using ADAMTS-12, an integrin and metalloprotease with thrombspondin motifsATHERSYS INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ATHERSYS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →